A Philly biotech got $60M from a TED initiative for AI in medicine
Every Cure will use the money to help repurpose existing therapies into treatments for different diseases, a strategy co-founder David Fajgenbaum says saved his own life.

Every Cure will use the money to help repurpose existing therapies into treatments for different diseases, a strategy co-founder David Fajgenbaum says saved his own life.